A pharmacovigilance system for treatment access and medical donation programs: The Max Foundation experience.
Ann Kim NovakowskiPat Garcia-GonzalezMichael WrigglesworthAndy StergachisPublished in: Globalization and health (2018)
International patient assistance programs that provide access to medicines can have an important role in assisting pharmaceutical companies in fulfilling their pharmacovigilance obligations. Adverse event information collected through PATS can potentially contribute to the overall body of knowledge on the safety of medicinal products.